Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Chicken Soup for the Soul Entertainment to Present at 40th Annual Canaccord Genuity Global Growth Conference
-
Chicken Soup for the Soul Entertainment to Present at 40th Annual Canaccord Genuity Global Growth Conference
-
Sprout Social to Present at Upcoming Investor Conferences
-
Mirum Pharmaceuticals to Present at the Canaccord Genuity 40th Annual Growth Conference
-
ICF to Present at the Canaccord Genuity 40th Annual Growth Conference
-
Cutera to Present at the Canaccord Genuity Growth Conference
-
Primo Water Corporation to Present at the Annual Canaccord Genuity Growth Conference
-
Canaccord Genuity Group Inc. Statement Regarding Recent Media Coverage
-
BuzBuz Capital and Inolife Announce Proposed Qualifying Transaction
-
Biogen (BIIB) Well Positioned After FDA Grants Priority Review - Canaccord Genuity
-
Canaccord Genuity Said to Hire Advisers to Explore Sale - Bloomberg
-
Zillow Group (ZG) PT Raised to $92 at Canaccord Genuity, Following Earnings
-
Livent's Paul Graves to Speak at the Canaccord Genuity 40th Annual Growth Conference
-
Blue Apron to Participate in the Canaccord Genuity 40th Annual Growth Conference
-
Schultze Special Purpose Acquisition Corp. Announces Filing of a Registration Statement on SEC Form S-4 in Connection with its Proposed Business Combination with Clever Leaves, a Large-Scale Pharmaceu
-
ACI Worldwide to Attend Upcoming Investor Conferences
-
Sigilon Therapeutics to Participate in Three Upcoming Investor Conferences
-
Nevro to Present at Canaccord Genuity 40th Annual Virtual Growth Conference
-
Quanterix (QTRX) Prices 2.65M Share Offering at $32/Share
-
Quanterix Prices Public Offering of Common Stock
-
Sustainable Innovation & Health Dividend Fund Announces Exchange Ratios
-
Quanterix (QTRX)to Offer Common Stock
-
Aspen Aerogels to Present at the Canaccord Genuity Growth Conference
-
Quanterix Announces Proposed Public Offering of Common Stock
-
Cortexyme Announces Webcasts of Investor Conference Presentations in August 2020
-
Pega to Present at Upcoming Investor Conferences
-
Merit Medical to Participate at Canaccord Genuity and Needham Conferences
-
Dropbox Announces Fiscal 2020 Second Quarter Results
-
Cara Therapeutics to Present at the Canaccord Genuity 40th Annual Growth Conference
-
Vapotherm to Present at the Canaccord Genuity 40th Annual Growth Conference
-
Cara Therapeutics to Present at the Canaccord Genuity 40th Annual Growth Conference
-
Canaccord Genuity Group Inc. Report on Voting Results
-
Inseego Corp. to Participate in Fireside Chat at the 40th Annual Canaccord Genuity Growth Conference
-
Acutus Medical (AFIB) IPO Opens 34% Higher
-
Mobivity to Present at the Canaccord Genuity 40th Annual Growth Conference
-
UPDATE: Acutus Medical Inc. (AFIB) Prices 8.23M Share IPO at $18/Sh
-
Wayfair (W) PT Raised to $340 at Canaccord Genuity, Following Earnings
-
Etsy (ETSY) PT Raised to $160 at Canaccord Genuity, Following Earnings
-
Liquid Media Retains Novus Merchant Partners as its Capital Markets Advisor
-
SailPoint to Participate at the Piper Sandler Digital Transformation Event, the Oppenheimer Technology, Internet & Communications Conference and the Canaccord Genuity Growth Conference
-
Deciphera Pharmaceuticals, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference
-
CryoLife to Participate in Upcoming Virtual Investor Conferences
-
Phunware to Present at Canaccord Genuity’s Annual Growth Conference
-
Rhythm Pharmaceuticals to Present Virtually at Canaccord Genuity 40th Annual Growth Conference
-
Neoleukin Therapeutics to Present at Canaccord Genuity 40th Annual Growth Conference
-
DLH to Participate in the Upcoming Canaccord Genuity Conference
-
Rhythm Pharmaceuticals to Present Virtually at Canaccord Genuity 40th Annual Growth Conference
-
PowerFleet Reports Second Quarter 2020 Financial Results
-
Neoleukin Therapeutics to Present at Canaccord Genuity 40th Annual Growth Conference
-
NAPCO Security Technologies to Present at the Canaccord Genuity 40th Annual Growth Conference on August 12, 2020

